Nanalysis Scientific Corp. (NSCIF)
OTCMKTS · Delayed Price · Currency is USD
0.1500
-0.0061 (-3.91%)
Sep 5, 2025, 2:58 PM EDT
Nanalysis Scientific Revenue
Nanalysis Scientific had revenue of 9.58M CAD in the quarter ending June 30, 2025, a decrease of -16.54%. This brings the company's revenue in the last twelve months to 43.03M, up 9.01% year-over-year. In the year 2024, Nanalysis Scientific had annual revenue of 45.50M with 59.82% growth.
Revenue (ttm)
43.03M CAD
Revenue Growth
+9.01%
P/S Ratio
0.58
Revenue / Employee
172.81K CAD
Employees
249
Market Cap
18.25M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 45.50M | 17.03M | 59.82% |
Dec 31, 2023 | 28.47M | 3.65M | 14.69% |
Dec 31, 2022 | 24.82M | 8.78M | 54.72% |
Dec 31, 2021 | 16.04M | 8.17M | 103.75% |
Dec 31, 2020 | 7.87M | -490.00K | -5.86% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jingbo Technology | 2.29M |
IPE Universal | 17.33M |
AI Unlimited Group | 101.00 |
Abaxx Technologies | 601.14K |
Fast Finance Pay | 10.35M |
Rand Worldwide | 86.70M |
EACO Corporation | 401.98M |
GSDT Fintech Group | 1.19M |
Nanalysis Scientific News
- 2 days ago - Nanalysis Chosen by IMRIS as Critical Component MRI Supplier - PRNewsWire
- 7 days ago - Nanalysis Scientific Corp. (NSCIF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Nanalysis Announces Second Quarter 2025 Results - PRNewsWire
- 15 days ago - Nanalysis Announces Second Quarter 2025 Conference Call - PRNewsWire
- 2 months ago - Nanalysis Announces First Regulated Assay for Pharmaceutical Quality Control via Benchtop NMR Accepted by the United States Pharmacopeia (USP) and European Pharmacopeia (Ph. Euro) - PRNewsWire
- 3 months ago - Nanalysis Scientific Corp. (NSCIF) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Nanalysis Announces First Quarter 2025 Results - PRNewsWire
- 4 months ago - Nanalysis Announces First Quarter 2025 Conference Call - PRNewsWire